ARCHIVES

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Gets 41.258 Bil. In Final FY 1986 Appropriations

November 29, 1985

Clinical Trials System “Slowly Unraveling,”

March 7, 2008

In Brief: House Appropriations Subcommitee Plans Hearing On NCI March 24; New DTP Director Sought

February 25, 1983

Decision to Cover New Colorectal Cancer Drugs, PET Scans.

February 4, 2005

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

Clearinghouse Opens With Predictable Controversy; Brown Urges ‘Open Minds’

November 12, 1976